This feasibility study focuses on Somatropin based formulations, as a case study for rapid detection of authentic and suspect counterfeit human growth hormone (hGH) using electrochemical detection. Since Somatropin is a controlled drug, a major barrier comes with the additional complexity of shipping it across borders to central testing laboratories. Therefore, a rapid, portable and cost-effective analytical technique is critical to the success of identifying and seizing the counterfeits before they reach patients.

Analytical equipment available to authenticate medical products including vaccines is usually relatively large, expensive and based in central testing laboratories that often requires samples to cross borders taking a long time to check.

The purpose of this work was to uniquely “fingerprint” through electrochemical testing of known Covid-19 vaccines to prove the ability to identify substandard and falsified products anywhere in the world, quickly and cost effectively

The purpose of this work was to identify through electrochemical testing the presence of hydrogen peroxide within process water.

This test is very flexible, enabling those that use hydrogen peroxide within their processes to monitor peroxide levels more effectively. Early identification of over-dosing or under-dosing prevents waste and reduces issues relating to paper quality (for example paper colour, excess microbial growth and “stickies”).

During the pandemic, rapid diagnosis of a previously unknown virus was critical.

The purpose of this work was to establish if it is possible to detect the SARS-CoV-2 (SCV2) virus using with the Eluceda E-Sens™ biosensor technology. We proved it was.